Watch to hear Dr. Mark Peyrot discuss methods to help and support patients struggling with diabetes.
V-Go is indicated for use in adult patients requiring insulin. A U-100 fast-acting insulin should be used with V-Go. Humalog® (insulin lispro [rDNA origin] injection) and NovoLog® (insulin aspart [rDNA origin] injection) have been tested by Valeritas, Inc. and found to be safe for use in V-Go. Humalog® is a registered trademark of Eli Lilly and Company. NovoLog® is a registered trademark of Novo Nordisk A/S. Individual results may vary
References: 1. Data from 2011 US Roper Diabetes Patient Market Study provided by GfK Custom Research LLC and distributed only with express written permission of GfK Custom Research LLC. This study is an annual survey of over 2,000 diabetes patients (n = 2,104 in 2011: 692 who use insulin) via telephone and internet. Confidential–Not for Distribution Without Permission from Valeritas and GfK Custom Research LLC. 2. Brod M, Rana A, Barnet A. Adherence patterns in patients with type 2 diabetes on basal insulin analogues: missed, mistimed and reduced doses. Curr Med Res Opin. 2012;28(12):1933-1946. 3. Randlov J, Poulsen J. How much do forgotten insulin injections matter to hemoglobin A1c in people with diabetes? A simulation study. Diabetes Science Tech. 2008;2(2):229-235. 4. Currie CJ, Peyrot M, Morgan CL, et al. The impact of treatment noncompliance on mortality in people with type 2 diabetes. Diabetes Care. 2012;35(6):1279-1284. 5. Carls GS, Tuttle E, Tan RD, et al. Understanding the gap between efficacy in randomized controlled trials and effectiveness in real-world use of GLP-1 RA and DPP-4 therapies in patients with type 2 diabetes. Diabetes Care. 2017;40:1469-1478.